By Chris Hutching
Friday 27th October 2000
|Text too small?|
C G Surgical's 10 million shares were issued at 8c recently and Southern Capital bought one million of them. A few early trades last week saw the shares change hands at 60c but this week a parcel of 5000 shares was traded at $1.70.
South Island businessman Mr Paterson, who is a founder shareholder and director of Southern Capital, identified the opportunity to invest in C G Surgical through his links with Otago University researchers.
Other recent fledgling bio-tech companies where Southern Capital has stakes include Blis, which owns patents over a cure for throat infections, and A2 Corporation, which claims patents over milk proteins that may have significance for some health conditions. After initial stagging on Blis and A2 shares issued at 10c, trades have settled to a narrower range around 80c and $2.30, still representing considerable paper profits for Southern Capital.
Managing director Graeme Wong said Southern Capital was retaining its stakes for now.
C G Surgical was developed by engineer Richard Cathro. It has patents over a titanium and teflon clip which prevents pressure on the spinal cord. Pressure can cause neurological-related complaints.
No comments yet
MARKET CLOSE: NZ shares gain as investors 'buy the rumour'; MRP becomes Mercury
NZ dollar falls vs yen as Bank of Japan delivers less stimulus than expected
Fletcher trims $12 mln from slimmed down Higgins acquisition
Moa stresses it has no undisclosed plans
Kingfish's Fisher says over-valued NZ shares have 'no room for earnings disappointment'
Investors press NZOG to resume dividends after return to profit
NZ business confidence dips in June as agriculture feels the pinch, construction stays positive
Statistics NZ delays June household labour force survey for two weeks
Todd gains clearance to sell 20% stake in former gold mine land to Coeur Mining
Bethunes signals capital raise will come if and when investment opportunity arises